{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:26:06Z","timestamp":1773480366344,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,23]],"date-time":"2015-05-23T00:00:00Z","timestamp":1432339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00223-015-0015-4","type":"journal-article","created":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T04:41:34Z","timestamp":1432269694000},"page":"58-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Effects of Re-challenge in Patients with a History of Acute Anterior Uveitis Following Intravenous Zoledronate"],"prefix":"10.1007","volume":"97","author":[{"given":"Dipika V.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borislav","family":"Mihov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian R.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles N. J.","family":"McGhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,23]]},"reference":[{"issue":"2","key":"15_CR1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.eye.6701461","volume":"19","author":"JM Durnian","year":"2005","unstructured":"Durnian JM, Olujohungbe A, Kyle G (2005) Bilateral acute uveitis and conjunctivitis after zoledronic acid therapy. Eye 19(2):221\u2013222","journal-title":"Eye"},{"issue":"7","key":"15_CR2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.clon.2006.04.013","volume":"18","author":"TCS Woo","year":"2006","unstructured":"Woo TCS, Joseph DJ, Wilkinson R (2006) Serious ocular complications of zoledronate. Clin Oncol (R Coll Radiol) 18(7):545\u2013546","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"15_CR3","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.4158\/EP11081.CR","volume":"17","author":"H Kaur","year":"2011","unstructured":"Kaur H, Uy C, Kelly J, Moses AM (2011) Orbital inflammatory disease in a patient treated with zoledronate. Endocr Pract 17(4):e101\u2013e103","journal-title":"Endocr Pract"},{"issue":"2","key":"15_CR4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00198-014-2872-5","volume":"26","author":"DV Patel","year":"2014","unstructured":"Patel DV, Bolland M, Nisa Z, Al-Abuwsi F, Singh M, Horne A, Reid IR, McGhee CN (2014) Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial. Osteoporos Int 26(2):499\u2013503","journal-title":"Osteoporos Int"},{"issue":"8842","key":"15_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0140-6736(93)93029-Z","volume":"341","author":"ES Siris","year":"1993","unstructured":"Siris ES (1993) Bisphosphonates and iritis. Lancet 341(8842):436\u2013437","journal-title":"Lancet"},{"issue":"12","key":"15_CR6","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3899\/jrheum.080273","volume":"35","author":"F Banal","year":"2008","unstructured":"Banal F, Briot K, Ayoub G, Dougados M, Roux C (2008) Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer. J Rheumatol 35(12):2458\u20132459","journal-title":"J Rheumatol"},{"issue":"4","key":"15_CR7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ophtha.2012.10.028","volume":"120","author":"DV Patel","year":"2013","unstructured":"Patel DV, Horne A, House M, Reid IR, McGhee CN (2013) The incidence of acute anterior uveitis after intravenous zoledronate. Ophthalmology 120(4):773\u2013776","journal-title":"Ophthalmology"},{"issue":"2","key":"15_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/8756-3282(95)00448-3","volume":"18","author":"A Sauty","year":"1996","unstructured":"Sauty A, Pecherstorfer M, Zimmer-Roth I, Fioroni P, Juillerat L, Markert M, Ludwig H, Leuenberger P, Burckhardt P, Thiebaud D (1996) Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone 18(2):133\u2013139","journal-title":"Bone"},{"issue":"9","key":"15_CR9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199903043400914","volume":"340","author":"V Kunzmann","year":"1999","unstructured":"Kunzmann V, Bauer E, Wilhelm M (1999) Gamma\/delta T-cell stimulation by pamidronate. N Engl J Med 340(9):737\u2013738","journal-title":"N Engl J Med"},{"issue":"9","key":"15_CR10","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1210\/jc.2010-0597","volume":"95","author":"IR Reid","year":"2010","unstructured":"Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM (2010) Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab 95(9):4380\u20134387","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"15_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/09273948.2014.968671","volume":"23","author":"NP Jones","year":"2015","unstructured":"Jones NP (2015) The Manchester Uveitis Clinic: The first 3000 patients, 2: uveitis manifestations, complications, medical and surgical management. Ocul Immunol Inflamm 23(2):127\u2013134","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"15_CR12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM200303203481225","volume":"348","author":"FW Fraunfelder","year":"2003","unstructured":"Fraunfelder FW, Fraunfelder FT (2003) Bisphosphonates and ocular inflammation. N Engl J Med 348(12):1187\u20131188","journal-title":"N Engl J Med"},{"issue":"2","key":"15_CR13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0002-9394(02)01840-8","volume":"135","author":"FW Fraunfelder","year":"2003","unstructured":"Fraunfelder FW, Fraunfelder FT, Jensvold B (2003) Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol 135(2):219\u2013222","journal-title":"Am J Ophthalmol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-015-0015-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-015-0015-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-015-0015-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:41:12Z","timestamp":1558698072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-015-0015-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,23]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1007\/s00223-015-0015-4","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,23]]}}}